Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2526240 | 0.98 | ALDH1A1 (0.31) | ALDH1A1RNPEPCYP1A2SLC7A5TSHR | |
| SCHEMBL49170 | 0.82 | — | — | |
| SCHEMBL1924410 | 0.80 | CHRM1 (0.30) | ALDH1A1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL9586717 | 0.75 | RNPEP (0.38) | ALDH1A1RNPEPSLC7A5TP53CHRM1 | |
| SCHEMBL180035 | 0.74 | RNPEP (0.50) | ALDH1A1RNPEPSLC7A5TP53ADRA1A | |
| SCHEMBL11213598 | 0.74 | — | — | |
| SCHEMBL13225821 | 0.73 | ENPEP (0.40) | ALDH1A1RNPEPSLC7A5TP53CHRM1 | |
| Hydrochloric Acid SCHEMBL27761977 | 0.72 | RNPEP (0.48) | ALDH1A1RNPEPSLC7A5TP53ADRA1A | |
| SCHEMBL11131728 | 0.72 | TP53 (0.43) | ALDH1A1RNPEPSLC7A5TP53 | |
| SCHEMBL6273797 | 0.70 | LMNA (0.36) | ALDH1A1RNPEPCYP1A2SLC7A5TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0582472-B1 | Non-magnetic particles | TODA KOGYO CORP (JP) | 1997-05-28 | — | — | EP | claimed |
| EP-0555879-B1 | Coating composition and process for manufacturing the same | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1997-05-07 | — | — | EP | claimed |
| EP-0242903-B1 | TACKIFIER COMPOSITION | NIPPON OIL CO. LTD. (JP) | 1992-06-24 | — | — | EP | claimed |
| US-20230135925-A1 | FLEXIBLE TUBE FOR ENDOSCOPE, ENDOSCOPIC MEDICAL DEVICE, AND METHODS FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-115449328-A | Flame-retardant silane modified polyether sealant as well as preparation method and application thereof | 广州市建筑科学研究院集团有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-111675987-B | Pressure sensitive adhesive | 德莎欧洲股份公司 | 2022-08-02 | — | — | CN | disclosed |
| US-20220204535-A1 | COMPOSITION, FILM, METHOD OF FORMING FILM, METHOD OF FORMING PATTERN, METHOD OF FORMING ORGANIC-UNDERLAYER-FILM REVERSE PATTERN, AND METHOD OF PRODUCING COMPOSITION | JSR CORPORATION (JP) | 2022-06-30 | — | — | US | disclosed |
| US-20200333706-A1 | PATTERNED SUBSTRATE-PRODUCING METHOD | JSR CORPORATION (JP) | 2020-10-22 | — | — | US | disclosed |
| CN-111675987-A | Pressure sensitive adhesive | 德莎欧洲股份公司 | 2020-09-18 | — | — | CN | disclosed |
| US-20200159121-A1 | METAL-CONTAINING FILM-FORMING COMPOSITION, METAL-CONTAINING FILM AND PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2020-05-21 | — | — | US | disclosed |
| EP-2826460-B1 | Emulsion containing a dispersion of bismuth oxychloride | OREAL (FR) | 2017-08-23 | — | — | EP | disclosed |
| WO-2006037902-A1 | MAKE-UP METHOD USING A MAGNETIC COMPOSITION CONTAINING AT LEAST ONE DIFFRACTIVE PIGMENT | L'OREAL (FR) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037906-A1 | MAKE-UP METHOD USING A MAGNETIC COMPOSITION COMPRISING AT LEAST ONE DYEING AGENT PRODUCING A COLOUR BY ABSORPTION OF AT LEAST PART OF THE VISIBLE SPECTRUM | L'OREAL (FR) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037903-A1 | MAKE-UP METHOD USING A MAGNETIC COMPOSITION CONTAINING AT LEAST ONE TINTING AGENT HAVING OPTICAL PROPERTIES WHICH ARE SENSITIVE TO AN EXTERNAL STIMULUS | L'OREAL (FR) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037907-A1 | MAKE-UP METHOD USING A MAGNETIC COMPOSITION, COMPRISING AT LEAST ONE INTERFERENTIAL PIGMENT | L'OREAL (FR) | 2006-04-13 | — | — | WO | disclosed |
| WO-2005102251-A2 | TREATMENT DEVICE CONTAINING A COSMETIC COMPOSITION | L'OREAL (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1588688-A1 | Range of cosmetic compositions for the skin, lips, hair or nails. | L'OREAL (FR) | 2005-10-26 | — | — | EP | disclosed |
| EP-1588687-A1 | Composition for use on the skin, lips and/or nails | L'OREAL (FR) | 2005-10-26 | — | — | EP | disclosed |
| EP-1586296-A1 | Cosmetic composition for application to the skin, lips and/or nails. | L'OREAL (FR) | 2005-10-19 | — | — | EP | disclosed |
| EP-1586295-A1 | Cosmetic composition for skin, lips and / or nails. | L'OREAL (FR) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204535-A1 | COMPOSITION, FILM, METHOD OF FORMING FILM, METHOD OF FORMING PATTERN, METHOD OF FORMING ORGANIC-UNDERLAYER-FILM REVERSE PATTERN, AND METHOD OF PRODUCING COMPOSITION | LEF1, APOL1, KNTC1 | ALDH1A1 2981/4885RNPEP 4738/4885CYP1A2 1422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.